Search

Search Bar
13/08/2022 A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry
Esteve-Pastor, MA, Rivera-Caravaca, JM, Ruiz-Ortiz, M, Muniz, J, Roldan-Rabadan, I, Otero, D, Lopez-Galvez, R, Cequier, A, Bertomeu-Martinez, V, Badimon, L, Anguita, M, Lip, GYH, Marin, F. A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry. EXPERT OPINION ON PHARMACOTHERAPY. 2022; 23(12)DOI:10.1080/14656566.2022.2109961. PMID:35924672. IF:3.200(Q3/6D).
01/08/2022 Acute effect of coffee on arterial stiffness and endothelial function in overweight and obese individuals: A randomized clinical trial
Pavao, TP, Chemello, D, Ferigollo, A, Saffi, MAL, Moresco, RN, Stein, CD, Emanuelli, T, Somacal, S, Moriguchi, EH, Badimon, L, Chagas, P. Acute effect of coffee on arterial stiffness and endothelial function in overweight and obese individuals: A randomized clinical trial. Clinical Nutrition Espen. 2022; 50DOI:10.1016/j.clnesp.2022.05.003. PMID:35871944. IF:(Q/D).
26/07/2022 DJ-1 interacts with the ectopic ATP-synthase in endothelial cells during acute ischemia and reperfusion
Gallinat, A, Badimon, L. DJ-1 interacts with the ectopic ATP-synthase in endothelial cells during acute ischemia and reperfusion. Scientific Reports. 2022; 12(1)DOI:10.1038/s41598-022-16998-3. PMID:35882968. IF:4.600(Q2/4D).
24/05/2022 Reduced Heart Failure and Mortality in Patients Receiving Statin Therapy Before Initial Acute Coronary Syndrome
Bugiardini, R, Yoon, J, Mendieta, G, Kedev, S, Zdravkovic, M, Vasiljevic, Z, Milicic, D, Manfrini, O, van der Schaar, M, Gale, CP, Bergami, M, Badimon, L, Cenko, E. Reduced Heart Failure and Mortality in Patients Receiving Statin Therapy Before Initial Acute Coronary Syndrome. JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2022; 79(20)DOI:10.1016/j.jacc.2022.03.354. PMID:35589164. IF:24.000(Q1/1D).
14/05/2022 Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV) a randomised controlled trial
Delgado-Lista J., Alcala-Diaz J.F., Torres-Peña J.D., Quintana-Navarro G.M., Fuentes F., Garcia-Rios A., Ortiz-Morales A.M., Perez-Caballero A.I., Yubero-Serrano E.M., Rangel-Zuñiga O.A., Camargo A., Rodriguez-Cantalejo F., Lopez-Segura F., Badimon L., Ordovas J.M., Perez-Jimenez F., Perez-Martinez P., Lopez-Miranda J., Almaden Peña Y., Aranda E., Arenas de Larriva A.P., Badimon J.J., Blanco-Molina A., Blanco-Rojo R., Bolivar-Muñoz J., Caballero-Villarraso J., Chica J., Corina A., Criado-Garcia J., Cruz-Teno C., Daponte-Codina A., de Teresa Galvan E., Delgado-Casado N., Estruch R., Fernandez J.M., Fernandez-Gandara C., Fuentes-Jimenez F., Garcia-Carpintero Fernandez-Pacheco S., Gomez-Delgado F., Gomez-Garduño A., Gomez-Luna P., Gomez-Luna M.J., Gonzalez-Guardia L., Gonzalez-Requero A.I., Gutierrez-Mariscal F.M., Haro-Mariscal C.M., Jimenez-Lucena R., Jimenez-Morales A.I., Leon-Acuña A., Marin-Hinojosa C., Meneses Alvarez M.E., Mesa-Luna D., Moya-Garrido M.N., Muñoz-Carvajal I., Navarro-Martos V., Ochoa J.J., Ortiz-Minuesa J.A., Pan M., Peña-Orihuela P., Perez-Corral I., Pi-Sunyer F.X., Ramirez-Lara I., Rodriguez-Artalejo F., Romero M.A., Roncero-Ramos I., Ruano-Ruiz J.A., Ruiz de Castroviejo J., Sanchez-Villegas P., Suarez de Lezo J., Vals-Delgado C., Valverde R., Visioli F.. Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV) a randomised controlled trial. LANCET. 2022; 399(10338)DOI:10.1016/S0140-6736(22)00122-2. PMID:35525255. IF:168.900(Q1/1D).
02/05/2022 Impact of Integrated Care Management on Clinical Outcomes in Atrial Fibrillation Patients: A Report From the FANTASIIA Registry
Esteve-Pastor, MA, Ruiz-Ortiz, M, Muniz, J, Roldan-Rabadan, I, Otero, D, Cequier, A, Bertomeu-Martinez, V, Badimon, L, Anguita, M, Lip, GYH, Marin, F. Impact of Integrated Care Management on Clinical Outcomes in Atrial Fibrillation Patients: A Report From the FANTASIIA Registry. Frontiers in Cardiovascular Medicine. 2022; 9DOI:10.3389/fcvm.2022.856222. PMID:35586656. IF:3.600(Q2/5D).
01/09/2025 Coronary revascularization and sex differences in cardiovascular mortality after myocardial infarction in 12 high and middle-income European countries
Cenko, E, Yoon, J, Bergami, M, Gale, CP, Vasiljevic, Z, Vavlukis, M, Kedev, S, Milicic, D, Dorobantu, M, Badimon, L, Manfrini, O, Bugiardini, R. Coronary revascularization and sex differences in cardiovascular mortality after myocardial infarction in 12 high and middle-income European countries. European Heart Journal-Quality of Care and Clinical Outcomes. 2025; 11(6)DOI:10.1093/ehjqcco/qcae035. PMID:38714331. IF:4.600(Q1/2D).
16/10/2024 New COST Action 'EUropean network to tackle METAbolic alterations in HEART failure' (EU-METAHEART)
Maack, C, Vilahur, G, Ruiz-Meana, M, Hausenloy, D. New COST Action 'EUropean network to tackle METAbolic alterations in HEART failure' (EU-METAHEART). EUROPEAN HEART JOURNAL. 2024; 45(42)DOI:10.1093/eurheartj/ehae457. PMID:39412117. IF:35.600(Q1/1D).
27/09/2024 EPAS1 Attenuates Atherosclerosis Initiation at Disturbed Flow Sites Through Endothelial Fatty Acid Uptake
Pirri, D, Tian, SY, Tardajos-Ayllon, B, Irving, SE, Donati, F, Allen, SP, Mammoto, T, Vilahur, G, Kabir, L, Bennett, J, Rasool, Y, Pericleous, C, Mazzei, G, McAllan, L, Scott, WR, Koestler, T, Zingg, U, Birdsey, GM, Miller, CL, Schenkel, T, Chambers, EV, Dunning, MJ, Serbanovic-Canic, J, Botrè, F, Mammoto, A, Xu, SW, Osto, E, Han, WP, Fragiadaki, M, Evans, PC. EPAS1 Attenuates Atherosclerosis Initiation at Disturbed Flow Sites Through Endothelial Fatty Acid Uptake. CIRCULATION RESEARCH. 2024; 135(8)DOI:10.1161/CIRCRESAHA.123.324054. PMID:39234692. IF:16.200(Q1/1D).
13/09/2024 Early coronary revascularization among 'stable' patients with non-ST-segment elevation acute coronary syndromes: the role of diabetes and age
Fabin, N, Cenko, E, Bergami, M, Yoon, J, Vadalà, G, Mendieta, G, Kedev, S, Kostov, J, Vavlukis, M, Vraynko, E, Milicic, D, Vasiljevic, Z, Zdravkovic, M, Badimon, L, Galassi, AR, Manfrini, O, Bugiardini, R. Early coronary revascularization among 'stable' patients with non-ST-segment elevation acute coronary syndromes: the role of diabetes and age. CARDIOVASCULAR RESEARCH. 2024; 120(16)DOI:10.1093/cvr/cvae190. PMID:39196713. IF:13.300(Q1/1D).
12/09/2024 European Heart Journal: a call to action
Crea, F, Badimon, L, Berry, C, De Caterina, R, Elliott, PM, Hatala, R, Libby, P, Linde, C, Tybjærg-Hansen, A. European Heart Journal: a call to action. EUROPEAN HEART JOURNAL. 2024; 45(36)DOI:10.1093/eurheartj/ehae588. PMID:39268706. IF:35.600(Q1/1D).
01/09/2024 Small Extracellular Vesicles in the Pericardium Modulate Macrophage Immunophenotype in Coronary Artery Disease
Ben-Aicha, S, Anwar, M, Vilahur, G, Martino, F, Kyriazis, PG, de Winter, N, Punjabi, PP, Angelini, GD, Sattler, S, Emanueli, C. Small Extracellular Vesicles in the Pericardium Modulate Macrophage Immunophenotype in Coronary Artery Disease. Jacc-Basic To Translational Science. 2024; 9(9)DOI:10.1016/j.jacbts.2024.05.003. PMID:39444932. IF:7.200(Q1/2D).
17/07/2024 Spleen in action for cardioprotection
Badimon, L, Kiss, A, Podesser, BK. Spleen in action for cardioprotection. EUROPEAN HEART JOURNAL. 2024; 45(34)DOI:10.1093/eurheartj/ehae420. PMID:39016156. IF:35.600(Q1/1D).
01/07/2024 The Influence of Metabolic Risk Factors on the Inflammatory Response Triggered by Myocardial Infarction: Bridging Pathophysiology to Treatment
Ramos-Regalado, L, Alcover, S, Badimon, L, Vilahur, G. The Influence of Metabolic Risk Factors on the Inflammatory Response Triggered by Myocardial Infarction: Bridging Pathophysiology to Treatment. Cells. 2024; 13(13)DOI:10.3390/cells13131125. PMID:38994977. IF:5.200(Q2/3D).
01/07/2024 Temporal trends in ICD prescription as primary prevention in non ischemic cardiomyopathy: 10 year single center registry
Crehuet, A, Abos, CM, Corcoy, MSI, Donlo, JM, Garcia, BC, Iniesta, MS, Ramon, CS, Benedicto, AM, Varo, AP, Ferrer, MD, Crespo, MC. Temporal trends in ICD prescription as primary prevention in non ischemic cardiomyopathy: 10 year single center registry. EUROPEAN JOURNAL OF HEART FAILURE. 2024; 26DOI:. PMID:. IF:10.800(Q1/1D).
01/07/2024 ICD prescription as primary prevention in DCM in NYHA class I: single center experience
Corcoy, MSI, Moliner-Abos, C, Llonch, C, Donlo, M, Garcia, C, Iniesta, S, Ramon, S, Benedicto, M, Varo, P, Ferrer, DA, Crespo, C, Perez, M. ICD prescription as primary prevention in DCM in NYHA class I: single center experience. EUROPEAN JOURNAL OF HEART FAILURE. 2024; 26DOI:. PMID:. IF:10.800(Q1/1D).
01/07/2024 ICD prescription as primary prevention in dilated cardiomyopathy over 70 years old after the DANISH trial: single center experience
Donlo, JM, Moliner-Abos, C, Corcoy, MSI, Llonch, AC, Martin, CA, Iniesta, MS, Ramon, CS, Benedicto, AM, Varo, AP, Ferrer, MD, Crespo, MC, Reiriz, IZ, Perez, SM. ICD prescription as primary prevention in dilated cardiomyopathy over 70 years old after the DANISH trial: single center experience. EUROPEAN JOURNAL OF HEART FAILURE. 2024; 26DOI:. PMID:. IF:10.800(Q1/1D).
13/06/2024 Killip scale reclassification according to lung ultrasound: Killip pLUS
Carreras-Mora, J, Vidal-Burdeus, M, Rodríguez-González, C, Simón-Ramón, C, Rodríguez-Sotelo, L, Sionis, A, Giralt-Borrell, T, Martínez-Membrive, MJ, Izquierdo-Marquisá, A, Cainzos-Achirica, M, Vaquerizo-Montilla, B, Rivas-Lasarte, M, Ribas-Barquet, N. Killip scale reclassification according to lung ultrasound: Killip pLUS. European Heart Journal-Acute Cardiovascular Care. 2024; 13(7)DOI:10.1093/ehjacc/zuae073. PMID:38832853. IF:4.600(Q1/2D).
01/06/2024 Unique Splicing of Lrp5 in the Brain: A New Player in Neurodevelopment and Brain Maturation
Luquero, A, Pimentel, N, Vilahur, G, Badimon, L, Borrell-Pages, M. Unique Splicing of Lrp5 in the Brain: A New Player in Neurodevelopment and Brain Maturation. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(12)DOI:10.3390/ijms25126763. PMID:38928468. IF:4.900(Q1/3D).
17/04/2024 The power of integrative medicine: A summary of the 58th annual scientific meeting of the European Society of Clinical Investigation, Barcelona June 5-7, 2024
Vilahur, G. The power of integrative medicine: A summary of the 58th annual scientific meeting of the European Society of Clinical Investigation, Barcelona June 5-7, 2024. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54(7)DOI:10.1111/eci.14216. PMID:38629625. IF:3.600(Q1/2D).
15/04/2024 Novel cutting edge nano-strategies to address old long-standing complications in cardiovascular diseases. A comprehensive review
Tesoro, L, Hernandez, I, Saura, M, Badimón, L, Zaragoza, C. Novel cutting edge nano-strategies to address old long-standing complications in cardiovascular diseases. A comprehensive review. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54(7)DOI:10.1111/eci.14208. PMID:38622800. IF:3.600(Q1/2D).
01/04/2024 Crosstalk of human coronary perivascular adipose-derived stem cells with vascular cells: role of tissue factor
Arderiu, G, Bejar, MT, Civit-Urgell, A, Peña, E, Badimon, L. Crosstalk of human coronary perivascular adipose-derived stem cells with vascular cells: role of tissue factor. BASIC RESEARCH IN CARDIOLOGY. 2024; 119(2)DOI:10.1007/s00395-024-01037-1. PMID:38430261. IF:8.000(Q1/1D).
15/03/2024 Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective effects in experimental myocardial infarction
Vilahur, G, Radike, M, Sutelman, P, Ben-Aicha, S, Gutiérrez, M, Casaní, L, Hovdal, D, Ongstad, EL, Gabrielsen, A, Hidalgo, A, Fjellström, O, Carlsson, L, Badimon, L. Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective effects in experimental myocardial infarction. EUROPEAN HEART JOURNAL. 2024; 45(17)DOI:10.1093/eurheartj/ehae107. PMID:38486376. IF:35.600(Q1/1D).
06/03/2024 Novel cardioprotective approaches in ischaemic heart disease
Vilahur, G, Radike, M, Badimon, L. Novel cardioprotective approaches in ischaemic heart disease. EUROPEAN HEART JOURNAL. 2024; 45(24)DOI:10.1093/eurheartj/ehae058. PMID:38445879. IF:35.600(Q1/1D).
02/03/2024 Narrowing the gap toward successful translational research in cardiovascular disease
Vilahur, G, Alcover, S, Magaldi, M. Narrowing the gap toward successful translational research in cardiovascular disease. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY. 2024; 326(3)DOI:10.1152/ajpheart.00038.2024. PMID:38305750. IF:4.100(Q1/2D).
01/03/2024 Traditional risk factors and premature acute coronary syndromes in South Eastern Europe: a multinational cohort
Bugiardini, R, Cenko, E, Yoon, J, Bergami, M, Vasiljevic, Z, Mendieta, G, Zdravkovic, M, Vavlukis, M, Kedev, S, Milic, D, Badimon, L, Manfrini, O. Traditional risk factors and premature acute coronary syndromes in South Eastern Europe: a multinational cohort. Lancet Regional Health-Europe. 2024; 38DOI:10.1016/j.lanepe.2023.100824. PMID:38476741. IF:13.000(Q1/1D).
01/03/2024 Differentiation of Adipose Tissue Mesenchymal Stem Cells into Endothelial Cells Depends on Fat Depot Conditions: Regulation by miRNA
Arderiu, G, Civit-Urgell, A, Diez-Caballero, A, Moscatiello, F, Ballesta, C, Badimon, L. Differentiation of Adipose Tissue Mesenchymal Stem Cells into Endothelial Cells Depends on Fat Depot Conditions: Regulation by miRNA. Cells. 2024; 13(6)DOI:10.3390/cells13060513. PMID:38534357. IF:5.200(Q2/3D).
01/01/2024 Seeing is believing: pathway strategies for a personalised non-invasive diagnosis of coronary artery disease
Sutelman P., Radike M., Vilahur G.. Seeing is believing: pathway strategies for a personalised non-invasive diagnosis of coronary artery disease. Internal and Emergency Medicine. 2024; 19(2)DOI:10.1007/s11739-023-03526-y. PMID:38315383. IF:3.800(Q1/2D).
20/12/2023 Interaction of heart failure and stroke: A clinical consensus statement of the ESC Council on Stroke, the Heart Failure Association (HFA) and the ESC Working Group on Thrombosis.
Doehner W, Böhm M, Boriani G, Christersson C, Coats AJS, Haeusler KG, Jones ID, Lip GYH, Metra M, Ntaios G, Savarese G, Shantsila E, Vilahur G, Rosano G. Interaction of heart failure and stroke: A clinical consensus statement of the ESC Council on Stroke, the Heart Failure Association (HFA) and the ESC Working Group on Thrombosis.. EUROPEAN JOURNAL OF HEART FAILURE. 2023; 25(12)DOI:10.1002/ejhf.3071. PMID:37905380. IF:16.900(Q1/1D).
01/12/2023 Adipose-Derived Stem Cells to Treat Ischemic Diseases: The Case of Peripheral Artery Disease
Arderiu, G, Civit-Urgell, A, Badimon, L. Adipose-Derived Stem Cells to Treat Ischemic Diseases: The Case of Peripheral Artery Disease. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(23)DOI:10.3390/ijms242316752. PMID:38069074. IF:4.900(Q1/3D).
23/08/2023 Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society
van Lennep, JER, Tokgozoglu, LS, Badimon, L, Dumanski, SM, Gulati, M, Hess, CN, Holven, KB, Kavousi, M, Kayikcioglu, M, Lutgens, E, Michos, ED, Prescott, E, Stock, JK, Tybjaerg-Hansen, A, Wermer, MJH, Benn, M. Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society. EUROPEAN HEART JOURNAL. 2023; 44(39)DOI:10.1093/eurheartj/ehad472. PMID:37611089. IF:38.100(Q1/1D).
22/08/2023 Management of patients on antithrombotic therapy with severe infections: a joint clinical consensus statement of the ESC Working Group on Thrombosis, the ESC Working Group on Atherosclerosis and Vascular Biology, and the International Society on Thrombosis and Haemostasis
Gigante, B, Levy, JH, van Gorp, E, Bartoloni, A, Bochaton-Piallat, ML, Back, M, ten Cate, H, Christersson, C, Ferreiro, JL, Geisler, T, Lutgens, E, Schulman, S, Storey, RF, Thachil, J, Vilahur, G, Liaw, PC, Rocca, B. Management of patients on antithrombotic therapy with severe infections: a joint clinical consensus statement of the ESC Working Group on Thrombosis, the ESC Working Group on Atherosclerosis and Vascular Biology, and the International Society on Thrombosis and Haemostasis. EUROPEAN HEART JOURNAL. 2023; 44(32)DOI:10.1093/eurheartj/ehad388. PMID:37439553. IF:38.100(Q1/1D).
24/07/2023 Atherosclerotic Plaque VASA Vasorum in Diabetic Macroangiopathy: WHEN IS Important, but also HOW IS Needed
Badimon L., Arderiu G.. Atherosclerotic Plaque VASA Vasorum in Diabetic Macroangiopathy: WHEN IS Important, but also HOW IS Needed. THROMBOSIS AND HAEMOSTASIS. 2023; 123(10)DOI:10.1055/a-2116-7261. PMID:37353212. IF:5.000(Q1/2D).
20/07/2023 A Novel ELISA for the Quantification of Serum Levels of 2 Glycosylated Variants of Apolipoprotein J: Biomarkers for Myocardial Ischemia
Encinas, LF, Lluch, N, Wu, AHB, Kaski, JC, Badimon, L, Cubedo, J. A Novel ELISA for the Quantification of Serum Levels of 2 Glycosylated Variants of Apolipoprotein J: Biomarkers for Myocardial Ischemia. Journal Of Applied Laboratory Medicine. 2023; 8(5)DOI:10.1093/jalm/jfad034. PMID:37473435. IF:(Q/D).
18/07/2023 Relationship Between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID-19 and Preexisting Cardiovascular Disease
Bergami, M, Manfrini, O, Nava, S, Caramori, G, Yoon, J, Badimon, L, Cenko, E, David, A, Demiri, I, Dorobantu, M, Fabin, N, Gheorghe-Fronea, O, Jankovic, R, Kedev, S, Ladjevic, N, Lasica, R, Loncar, G, Mancuso, G, Mendieta, G, Milicic, D, Mjehovic, P, Pasalic, M, Petrovic, M, Poposka, L, Scarpone, M, Stefanovic, M, van der Schaar, M, Vasiljevic, Z, Vavlukis, M, Pittao, MLV, Vukomanovic, V, Zdravkovic, M, Bugiardini, R. Relationship Between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID-19 and Preexisting Cardiovascular Disease. Journal of the American Heart Association. 2023; 12(14)DOI:10.1161/JAHA.122.028939. PMID:37449568. IF:5.000(Q1/2D).
01/07/2023 Statins revisited: therapeutic applications beyond lipid lowering?
Badimon, L, Mendieta, G, Vilahur, G. Statins revisited: therapeutic applications beyond lipid lowering?. EUROPEAN HEART JOURNAL. 2023; 44(25)DOI:10.1093/eurheartj/ehad324. PMID:37316965. IF:38.100(Q1/1D).
04/05/2023 The unknown functions of a known protein: the case of coagulation factor XI
van der Vorst, EPC, Badimon, L. The unknown functions of a known protein: the case of coagulation factor XI. CARDIOVASCULAR RESEARCH. 2023; 119(7)DOI:10.1093/cvr/cvad066. PMID:37141257. IF:10.400(Q1/1D).
01/04/2023 The gut microbiome dysbiosis is recovered by restoring a normal diet in hypercholesterolemic pigs
Schoch, L, Sutelman, P, Suades, R, Badimon, L, Moreno-Indias, I, Vilahur, G. The gut microbiome dysbiosis is recovered by restoring a normal diet in hypercholesterolemic pigs. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2023; 53(4)DOI:10.1111/eci.13927. PMID:36453873. IF:4.400(Q1/2D).
25/03/2023 Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV)
Sanchez-Guijo, F, Avendano-Sola, C, Badimon, L, Bueren, JA, Canals, JM, Delgadillo, J, Delgado, J, Eguizabal, C, Fernandez-Santos, ME, Garcia-Olmo, D, Gonzalez-Aseguinolaza, G, Juan, M, Martin, F, Mata, R, Montserrat, N, Perez-Martinez, A, Perez-Simon, JA, Prosper, F, Urbano-Ispizua, A, Zapata, AG, Sureda, A, Moraleda, JM. Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV). BONE MARROW TRANSPLANTATION. 2023; 58(6)DOI:10.1038/s41409-023-01962-0. PMID:36966215. IF:4.500(Q1/2D).
15/03/2023 A primordial obstacle in cardioprotection: the answer resides in our genes
Vilahur, G. A primordial obstacle in cardioprotection: the answer resides in our genes. CARDIOVASCULAR RESEARCH. 2023; 119(3)DOI:10.1093/cvr/cvad034. PMID:36919864. IF:10.400(Q1/1D).
01/03/2023 Gender-dependent impact of COVID-19 lockdown on metabolic and psychological aspects
Bonfrate, L, Di Ciaula, A, Khalil, M, Farella, I, Chirico, R, Vilahur, G, Portincasa, P. Gender-dependent impact of COVID-19 lockdown on metabolic and psychological aspects. Internal and Emergency Medicine. 2023; 18(2)DOI:10.1007/s11739-022-03173-9. PMID:36703077. IF:3.200(Q1/2D).
21/01/2023 Acute, periprocedural and longterm antithrombotic therapy in older adults 2022 Update by the ESC Working Group on Thrombosis
Andreotti, F, Geisler, T, Collet, JP, Gigante, B, Gorog, DA, Halvorsen, S, Lip, GYH, Morais, J, Navarese, EP, Patrono, C, Rocca, B, Rubboli, A, Sibbing, D, Storey, RF, Verheugt, FWA, Vilahur, G. Acute, periprocedural and longterm antithrombotic therapy in older adults 2022 Update by the ESC Working Group on Thrombosis. EUROPEAN HEART JOURNAL. 2023; 44(4)DOI:10.1093/eurheartj/ehac515. PMID:36477865. IF:38.100(Q1/1D).
18/01/2023 Sex differences and disparities in cardiovascular outcomes of COVID-19
Bugiardini, R, Nava, S, Caramori, G, Yoon, J, Badimon, L, Bergami, M, Cenko, E, David, A, Demiri, I, Dorobantu, M, Fronea, O, Jankovic, R, Kedev, S, Ladjevic, N, Lasica, R, Loncar, G, Mancuso, G, Mendieta, G, Milicic, D, Mjehovic, P, Pasalic, M, Petrovic, M, Poposka, L, Scarpone, M, Stefanovic, M, van der Schaar, M, Vasiljevic, Z, Vavlukis, M, Pittao, MLV, Vukomanovic, V, Zdravkovic, M, Manfrini, O. Sex differences and disparities in cardiovascular outcomes of COVID-19. CARDIOVASCULAR RESEARCH. 2023; 119(5)DOI:10.1093/cvr/cvad011. PMID:36651866. IF:10.400(Q1/1D).
09/01/2023 Burden of infectious disease studies in Europe and the United Kingdom: a review of methodological design choices
Charalampous P., Haagsma J.A., Jakobsen L.S., Gorasso V., Noguer I., Padron-Monedero A., Sarmiento R., Santos J.V., Mcdonald S.A., Plass D., Wyper G.M.A., Assunção R., Von Der Lippe E., Ádám B., Alkerwi A., Arabloo J., Baltazar A.L., Bikbov B., Borrell-Pages M., Brus I., Burazeri G., Chaintoutis S.C., Chen-Xu J., Chkhaberidze N., Cilovic-Lagarija S., Corso B., Cuschieri S., Di Bari C., Dopelt K., Economou M., Emeto T.I., Fantke P., Fischer F., Freitas A., García-González J.M., Gazzelloni F., Gissler M., Gkitakou A., Gulmez H., Gunes S., Haller S., Haneef R., Hincapié C.A., Hynds P., Idavain J., Ilic M., Ilic I., Isola G., Kabir Z., Kamusheva M., Kolkhir P., Konar N.M., Kostoulas P., Kulimbet M., La Vecchia C., Lauriola P., Levi M., Majer M., Mechili E.A., Monasta L., Mondello S., Muñoz Laguna J., Nena E., Ng E.S.W., Nguewa P., Niranjan V., Nola I.A., O'caoimh R., Obradovic M., Pallari E., Peyroteo M., Pinheiro V., Pranjic N., Reina Ortiz M., Riva S., Santoso C.M.A., Santric Milicevic M., Schmitt T., Speybroeck N., Sprügel M., Steiropoulos P., Stevanovic A., Thygesen L.C., Tozija F., Unim B., Bektas Uysal H., Varga O., Vasic M., Vieira R.J., Yigit V., Devleesschauwer B., Pires S.M.. Burden of infectious disease studies in Europe and the United Kingdom: a review of methodological design choices. EPIDEMIOLOGY & INFECTION. 2023; 151DOI:10.1017/S0950268823000031. PMID:36621004. IF:2.500(Q2/4D).
01/01/2023 Type 2 Diabetes in Obesity: A Systems Biology Study on Serum and Adipose Tissue Proteomic Profiles
Arderiu G., Mendieta G., Gallinat A., Lambert C., Díez-Caballero A., Ballesta C., Badimon L.. Type 2 Diabetes in Obesity: A Systems Biology Study on Serum and Adipose Tissue Proteomic Profiles. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(1)DOI:10.3390/ijms24010827. PMID:36614270. IF:4.900(Q1/3D).
01/01/2023 The European Society of Cardiology Working Group on Thrombosis
Rubboli A., Gorog D.A., Vilahur G.. The European Society of Cardiology Working Group on Thrombosis. EUROPEAN HEART JOURNAL. 2023; 44(25)DOI:10.1093/eurheartj/ehad063. PMID:36814406. IF:38.100(Q1/1D).
20/11/2022 DJ-1 regulates mitochondrial gene expression during ischemia and reperfusion
Gallinat, A, Rakovic, A, Klein, C, Badimon, L. DJ-1 regulates mitochondrial gene expression during ischemia and reperfusion. FREE RADICAL BIOLOGY AND MEDICINE. 2022; 193DOI:10.1016/j.freeradbiomed.2022.10.315. PMID:36341940. IF:7.400(Q1/2D).
01/11/2022 Novel Antithrombotic Agents in Ischemic Cardiovascular Disease: Progress in the Search for the Optimal Treatment
Barriuso, I, Worner, F, Vilahur, G. Novel Antithrombotic Agents in Ischemic Cardiovascular Disease: Progress in the Search for the Optimal Treatment. Journal of Cardiovascular Development and Disease. 2022; 9(11)DOI:10.3390/jcdd9110397. PMID:36421932. IF:2.400(Q3/7D).
05/09/2022 Current Status and Future Direction of Antithrombotic Therapy for Patients with STEMI Undergoing Primary PCI
Vogel, RF, Delewi, R, Badimon, L, Angiolillo, DJ, Vlachojannis, GJ. Current Status and Future Direction of Antithrombotic Therapy for Patients with STEMI Undergoing Primary PCI. Reviews in Cardiovascular Medicine. 2022; 23(9)DOI:10.31083/j.rcm2309297. PMID:. IF:2.700(Q3/6D).
01/01/2022 Comparación de dos programas de posprocesamiento de imágenes de cardiorresonancia magnética en un modelo porcino de infarto de miocardio
Radike M., Ben-Aicha S., Gutiérrez M., Hidalgo A., Badimón L., Vilahur G.. Comparación de dos programas de posprocesamiento de imágenes de cardiorresonancia magnética en un modelo porcino de infarto de miocardio. REVISTA ESPANOLA DE CARDIOLOGIA. 2022; 76(2)DOI:10.1016/j.recesp.2022.06.007. PMID:35809893. IF:5.900(Q1/3D).
01/01/2022 European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment
Lee G.A., Aktaa S., Baker E., Gale C.P., Yaseen I.F., Gulati G., Asteggiano R., Szmit S., Cohen-Solal A., Abdin A., Jurczak W., Garrido Lopez P., Sverdlov A.L., Tocchetti C.G., Barac A., Parrini I., Zamorano P., Iakobishvili Z., Pudil R., Badimon L., Kirby A.M., Blaes A.H., Farmakis D., Curigliano G., Stephens R., Lyon A.R., Lopez-Fernandez T.. European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment. European Heart Journal-Quality of Care and Clinical Outcomes. 2022; 9(1)DOI:10.1093/ehjqcco/qcac070. PMID:36316010. IF:5.200(Q2/3D).
01/01/2022 Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patients
Pérez de Isla L., Alonso R., Argüeso R., Muñiz-Grijalvo O., Álvarez-Baños P., Badimón L., Watts G.F., Mata P.. Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patients. Journal of Clinical Lipidology. 2022; 16(5)DOI:10.1016/j.jacl.2022.07.007. PMID:35906178. IF:4.400(Q2/3D).
01/01/2022 Percutaneous tricuspid valve repair after orthotopic heart transplantation
Maestro Benedicto A., Asmarats Serra L., Li C.H.P., Mirabet Pérez S.. Percutaneous tricuspid valve repair after orthotopic heart transplantation. Rec: Cardioclinics. 2022; 57(2)DOI:10.1016/j.rccl.2021.12.002. PMID:. IF:(Q/D).
01/01/2022 Variables affecting the quality of anticoagulation in atrial fibrillation patients newly initiating vitamin K antagonists: Insights from the national and multicentre SULTAN registry
Rivera-Caravaca J.M., Badimón L., Ferreira-Gonzalez I., Gómez-Doblas J.J., Roca-Luque I., Lekuona I., Jimenez-Candil J., Rodríguez-Padial L., González-Juanatey C., Calvo-Jambrina R., Fácila L., Ruiz-Ortiz M., Anguita M., Marín F.. Variables affecting the quality of anticoagulation in atrial fibrillation patients newly initiating vitamin K antagonists: Insights from the national and multicentre SULTAN registry. EUROPACE. 2022; 24(1)DOI:10.1093/europace/euab131. PMID:34115857. IF:6.100(Q1/3D).
01/10/2025 Monocyte/Macrophages: Unexpected Allies in the Fight Against Arterial Thrombosis?
Vilahur, G, Borrell-Pagés, M. Monocyte/Macrophages: Unexpected Allies in the Fight Against Arterial Thrombosis?. THROMBOSIS AND HAEMOSTASIS. 2025; 125(10)DOI:10.1055/a-2641-6568. PMID:40614767. IF:4.300(Q1/2D).
01/10/2025 Immunometabolism in heart failure
Andreadou, I, Ghigo, A, Nikolaou, PE, Swirski, FK, Thackeray, JT, Heusch, G, Vilahur, G. Immunometabolism in heart failure. Nature Reviews Cardiology. 2025; 22(10)DOI:10.1038/s41569-025-01165-8. PMID:40544171. IF:44.200(Q1/1D).
30/09/2025 Myocardial infarction induces endothelial dysfunction with independence of cardiovascular risk factors
Jimenez-Trinidad, FR, Solanes, N, Arrieta, M, Llonch, B, Roque, M, Freixa, X, Brugaletta, S, Ortega-Paz, L, Rodriguez, JJ, Cepas-Guillen, P, Vilhaur, G, Sabate, M, Dantas, AP, Tura-Ceide, O, Rigol, M. Myocardial infarction induces endothelial dysfunction with independence of cardiovascular risk factors. ANGIOGENESIS. 2025; 28(4)DOI:10.1007/s10456-025-10006-8. PMID:41028611. IF:9.200(Q1/1D).
01/08/2025 Flavonoids for Myocardial Ischemia-Reperfusion Injury?
Birnbaum, Y, Vilahur, G. Flavonoids for Myocardial Ischemia-Reperfusion Injury?. CARDIOVASCULAR DRUGS AND THERAPY. 2025; 39(4)DOI:10.1007/s10557-025-07688-z. PMID:40163234. IF:3.100(Q2/4D).
01/08/2025 Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation
Carbone, F, Després, JP, Ioannidis, JPA, Neeland, IJ, Garruti, G, Busetto, L, Liberale, L, Ministrini, S, Vilahur, G, Schindler, TH, Macedo, MP, Di Ciaula, A, Krawczyk, M, Geier, A, Baffy, G, Faienza, MF, Farella, I, Santoro, N, Frühbeck, G, Yárnoz-Esquiroz, P, Gómez-Ambrosi, J, Chávez-Manzanera, E, Vázquez-Velázquez, V, Oppert, JM, Kiortsis, DN, Sbraccia, P, Zoccali, C, Portincasa, P, Montecucco, F. Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2025; 55(8)DOI:10.1111/eci.70059. PMID:40371883. IF:3.600(Q1/2D).
01/08/2025 Roadmap for alleviating the manifestations of ageing in the cardiovascular system
Liberale, L, Tual-Chalot, S, Sedej, S, Ministrini, S, Georgiopoulos, G, Grunewald, M, Bäck, M, Bochaton-Piallat, ML, Boon, RA, Ramos, GC, de Winther, MPJ, Drosatos, K, Evans, PC, Ferguson, JF, Forslund-Startceva, SK, Goettsch, C, Giacca, M, Haendeler, J, Kallikourdis, M, Ketelhuth, DFJ, Koenen, RR, Lacolley, P, Lutgens, E, Maffia, P, Miwa, S, Monaco, C, Montecucco, F, Norata, GD, Osto, E, Richardson, GD, Riksen, NP, Soehnlein, O, Spyridopoulos, I, Van Linthout, S, Vilahur, G, Wentzel, JJ, Andrés, V, Badimon, L, Benetos, A, Binder, CJ, Brandes, RP, Crea, F, Furman, D, Gorbunova, V, Guzik, TJ, Hill, JA, Luescher, TF, Mittelbrunn, M, Nencioni, A, Netea, MG, Passos, JF, Stamatelopoulos, KS, Tavernarakis, N, Ungvari, Z, Wu, JC, Kirkland, JL, Camici, GG, Dimmeler, S, Kroemer, G, Abdellatif, M, Stellos, K. Roadmap for alleviating the manifestations of ageing in the cardiovascular system. Nature Reviews Cardiology. 2025; 22(8)DOI:10.1038/s41569-025-01130-5. PMID:39972009. IF:44.200(Q1/1D).